Variant report

Variant	nsv579592
Chromosome Location	chr19:41381501-41389306
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:62)
CpG islands
(count:367)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:62 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
2	CTCF	chr19:41387561-41387588	LNCaP	prostate:	n/a	n/a
3	CTCF	chr19:41386384-41386566	K562	blood:	n/a	n/a
4	CTCF	chr19:41386284-41386617	K562	blood:	n/a	n/a
5	CTCF	chr19:41386301-41386581	K562	blood:	n/a	n/a
6	CTCF	chr19:41386312-41386552	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr19:41381740-41381820	GM13976	blood:	n/a	n/a
8	CTCF	chr19:41388830-41388853	LNCaP	prostate:	n/a	n/a
9	CTCF	chr19:41386233-41386588	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr19:41386288-41386587	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr19:41386320-41386470	HEK293	kidney:	n/a	n/a
12	CTCF	chr19:41381744-41381801	Spleen_OC	spleen:	n/a	n/a
13	CTCF	chr19:41386434-41386449	K562	blood:	n/a	n/a
14	CTCF	chr19:41383928-41383999	LNCaP	prostate:	n/a	n/a
15	CTCF	chr19:41386211-41386665	K562	blood:	n/a	n/a
16	E2F6	chr19:41381386-41381592	K562	blood:	n/a	n/a
17	EGR1	chr19:41381455-41381600	K562	blood:	n/a	n/a
18	ELF1	chr19:41381308-41381629	K562	blood:	n/a	n/a
19	ELF1	chr19:41381301-41381621	K562	blood:	n/a	n/a
20	GABPA	chr19:41381394-41381588	K562	blood:	n/a	n/a
21	GATA2	chr19:41387355-41387455	SH-SY5Y	brain:	n/a	chr19:41387370-41387377 chr19:41387370-41387380 chr19:41387368-41387378 chr19:41387370-41387377 chr19:41387368-41387377 chr19:41387370-41387377
22	HEY1	chr19:41381295-41382001	K562	blood:	n/a	n/a
23	HEY1	chr19:41381432-41381922	K562	blood:	n/a	n/a
24	IRF4	chr19:41381461-41381916	GM12878	blood:	n/a	n/a
25	MAX	chr19:41381495-41381741	NB4	blood:	n/a	n/a
26	MAX	chr19:41381383-41381622	K562	blood:	n/a	n/a
27	MAX	chr19:41386259-41386608	H1-hESC	embryonic stem cell:	n/a	n/a
28	MAZ	chr19:41381489-41381679	K562	blood:	n/a	n/a
29	MYC	chr19:41381657-41381790	K562	blood:	n/a	n/a
30	MYC	chr19:41381792-41381803	K562	blood:	n/a	n/a
31	MYC	chr19:41381542-41381562	K562	blood:	n/a	n/a
32	POLR2A	chr19:41381428-41381856	SK-N-MC	brain:	n/a	n/a
33	POLR2A	chr19:41381532-41381761	H1-hESC	embryonic stem cell:	n/a	n/a
34	POLR2A	chr19:41386273-41386431	H1-hESC	embryonic stem cell:	n/a	n/a
35	POLR2A	chr19:41386101-41386269	H1-hESC	embryonic stem cell:	n/a	n/a
36	POLR2A	chr19:41381535-41381692	H1-hESC	embryonic stem cell:	n/a	n/a
37	POLR2A	chr19:41381460-41381607	K562	blood:	n/a	n/a
38	POLR2A	chr19:41381377-41381625	HL-60	blood:	n/a	n/a
39	POLR2A	chr19:41386159-41386584	H1-hESC	embryonic stem cell:	n/a	n/a
40	POLR2A	chr19:41381476-41381900	GM12878	blood:	n/a	n/a
41	POLR2A	chr19:41382311-41382594	HL-60	blood:	n/a	n/a
42	POLR2A	chr19:41381345-41381789	K562	blood:	n/a	n/a
43	RAD21	chr19:41386373-41386596	H1-hESC	embryonic stem cell:	n/a	n/a
44	RAD21	chr19:41386302-41386499	K562	blood:	n/a	n/a
45	RAD21	chr19:41386294-41386634	H1-hESC	embryonic stem cell:	n/a	n/a
46	RAD21	chr19:41386283-41386608	H1-hESC	embryonic stem cell:	n/a	n/a
47	RCOR1	chr19:41381343-41381527	K562	blood:	n/a	n/a
48	SPI1	chr19:41381476-41382082	GM12878	blood:	n/a	n/a
49	SPI1	chr19:41381508-41381950	GM12891	blood:	n/a	n/a
50	SPI1	chr19:41381380-41381636	HL-60	blood:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41383654-41383704	SKMC	muscle:	n/a
2	chr19:41383654-41383704	SKMC	muscle:	n/a
3	chr19:41385865-41385915	HMEC	breast:	n/a
4	chr19:41385865-41385915	HCF	heart:	n/a
5	chr19:41383654-41383704	HCF	heart:	n/a
6	chr19:41388232-41388282	ProgFib	skin:	n/a
7	chr19:41386441-41386491	GM12892	blood:	n/a
8	chr19:41388232-41388282	AoSMC	blood vessel:	n/a
9	chr19:41388232-41388282	BE2_C	brain:	n/a
10	chr19:41388232-41388282	HCF	heart:	n/a
11	chr19:41386441-41386491	Hepatocyte	liver:	n/a
12	chr19:41386507-41386557	AG04449	skin:	fetal
13	chr19:41383654-41383704	HRCEpiC	kidney:	n/a
14	chr19:41383654-41383704	ovcar-3	ovarian:	n/a
15	chr19:41388232-41388282	HCT-116	colon:	n/a
16	chr19:41386441-41386491	MCF10A-Er-Src	breast:	n/a
17	chr19:41386441-41386491	BE2_C	brain:	n/a
18	chr19:41386507-41386557	HCT-116	colon:	n/a
19	chr19:41388384-41388434	CMK	blood:	n/a
20	chr19:41388384-41388434	HepG2	liver:	n/a
21	chr19:41385865-41385915	AG09309	skin:	n/a
22	chr19:41386507-41386557	Hepatocyte	liver:	n/a
23	chr19:41388232-41388282	A549	lung:	n/a
24	chr19:41386441-41386491	HCF	heart:	n/a
25	chr19:41386507-41386557	CMK	blood:	n/a
26	chr19:41388384-41388434	Jurkat	blood:	n/a
27	chr19:41388384-41388434	MCF-7	breast:	n/a
28	chr19:41386441-41386491	LNCaP	prostate:	n/a
29	chr19:41386441-41386491	HRPEpiC	eye:	n/a
30	chr19:41388232-41388282	GM12878	blood:	n/a
31	chr19:41386507-41386557	AG09309	skin:	n/a
32	chr19:41386507-41386557	AG10803	skin:	n/a
33	chr19:41385865-41385915	Jurkat	blood:	n/a
34	chr19:41388384-41388434	NHDF-neo	bronchial:	n/a
35	chr19:41383654-41383704	AoSMC	blood vessel:	n/a
36	chr19:41383654-41383704	Jurkat	blood:	n/a
37	chr19:41386507-41386557	HNPCEpiC	eye:	n/a
38	chr19:41385865-41385915	NH-A	brain:	n/a
39	chr19:41386441-41386491	ProgFib	skin:	n/a
40	chr19:41388384-41388434	HCT-116	colon:	n/a
41	chr19:41385865-41385915	HIPEpiC	eye:	n/a
42	chr19:41386507-41386557	PFSK-1	brain:	n/a
43	chr19:41385865-41385915	MCF10A-Er-Src	breast:	n/a
44	chr19:41385865-41385915	PFSK-1	brain:	n/a
45	chr19:41386507-41386557	BE2_C	brain:	n/a
46	chr19:41385865-41385915	NT2-D1	testis:	n/a
47	chr19:41388232-41388282	AG09319	gingival:	n/a
48	chr19:41386441-41386491	GM12891	blood:	n/a
49	chr19:41388232-41388282	PrEC	prostate:	n/a
50	chr19:41388384-41388434	AoSMC	blood vessel:	n/a

No data

Variant related genes	Relation type
CYP2A7	TF binding region
CYP2A7	CpG island

Extended variants
information (count: 660 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:660 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1060096	chr19:41381501-41381502	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs531039163	chr19:41381502-41381503	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs1060095	chr19:41381503-41381504	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs1060094	chr19:41381510-41381511	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs188144723	chr19:41381516-41381517	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs370835631	chr19:41381517-41381518	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs568872305	chr19:41381532-41381533	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs576804869	chr19:41381534-41381535	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs1060091	chr19:41381538-41381539	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs1060090	chr19:41381540-41381541	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs1060089	chr19:41381542-41381543	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs1060088	chr19:41381545-41381546	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs1060087	chr19:41381549-41381550	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs192884225	chr19:41381567-41381568	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs146104447	chr19:41381575-41381576	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs1061607	chr19:41381579-41381580	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs199916845	chr19:41381583-41381584	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs370699685	chr19:41381595-41381596	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs534881248	chr19:41381611-41381612	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs553549965	chr19:41381614-41381615	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs141182893	chr19:41381618-41381619	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs374369863	chr19:41381624-41381625	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs184466431	chr19:41381629-41381630	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs575000397	chr19:41381638-41381639	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs370367449	chr19:41381643-41381644	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs12460590	chr19:41381647-41381648	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs72547584	chr19:41381656-41381657	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs575233049	chr19:41381670-41381671	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs200525410	chr19:41381671-41381672	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs564225833	chr19:41381673-41381674	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs71358943	chr19:41381683-41381684	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs202210796	chr19:41381697-41381698	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs201022572	chr19:41381703-41381704	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs142299028	chr19:41381717-41381718	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs201393166	chr19:41381762-41381763	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs529128750	chr19:41381763-41381764	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs12462918	chr19:41381771-41381772	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs550890415	chr19:41381794-41381795	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs569214404	chr19:41381805-41381806	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs539422822	chr19:41381834-41381835	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs551422601	chr19:41381839-41381840	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs11083575	chr19:41381840-41381841	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs533905259	chr19:41381844-41381845	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs11083576	chr19:41381868-41381869	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs56198581	chr19:41381875-41381876	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs553254369	chr19:41381901-41381902	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs10413473	chr19:41381936-41381937	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs2453801	chr19:41381947-41381948	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs561616702	chr19:41381955-41381956	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs530677704	chr19:41382010-41382011	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:89 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41378400-41382200	Weak transcription	Liver	Liver
2	chr19:41381000-41381600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
3	chr19:41381000-41381600	Enhancers	Primary T cells from cord blood	blood
4	chr19:41381000-41381800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr19:41381000-41381800	Enhancers	K562	blood
6	chr19:41381000-41382000	Enhancers	Primary T helper cells PMA-I stimulated	--
7	chr19:41381000-41382000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
8	chr19:41381000-41382200	Enhancers	Primary T helper naive cells from peripheral blood	blood
9	chr19:41381000-41382200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
10	chr19:41381000-41382200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
11	chr19:41381000-41382400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
12	chr19:41381000-41382400	Enhancers	Primary T killer memory cells from peripheral blood	blood
13	chr19:41381200-41381600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
14	chr19:41381200-41381600	Active TSS	H9 Cell Line	embryonic stem cell
15	chr19:41381200-41381600	Active TSS	Primary monocytes fromperipheralblood	blood
16	chr19:41381200-41381600	Active TSS	Primary B cells from peripheral blood	blood
17	chr19:41381200-41381600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
18	chr19:41381200-41381600	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
19	chr19:41381200-41381600	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
20	chr19:41381200-41381600	Flanking Active TSS	Adipose Nuclei	Adipose
21	chr19:41381200-41381600	Active TSS	Duodenum Mucosa	Duodenum
22	chr19:41381200-41381600	Flanking Active TSS	Fetal Intestine Large	intestine
23	chr19:41381200-41381600	Enhancers	Placenta	Placenta
24	chr19:41381200-41381800	Active TSS	ES-I3 Cell Line	embryonic stem cell
25	chr19:41381200-41381800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
26	chr19:41381200-41381800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
27	chr19:41381200-41381800	Active TSS	Primary T cells fromperipheralblood	blood
28	chr19:41381200-41381800	Enhancers	Fetal Intestine Small	intestine
29	chr19:41381200-41382000	Enhancers	Primary hematopoietic stem cells short term culture	blood
30	chr19:41381200-41382200	Active TSS	iPS-20b Cell Line	embryonic stem cell
31	chr19:41381400-41381600	Flanking Active TSS	Primary B cells from cord blood	blood
32	chr19:41381400-41381600	Enhancers	Primary hematopoietic stem cells	blood
33	chr19:41381400-41381600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
34	chr19:41381400-41381600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
35	chr19:41381400-41381800	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr19:41381400-41381800	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr19:41381400-41381800	Active TSS	Pancreas	Pancrea
38	chr19:41381400-41381800	Active TSS	Right Ventricle	heart
39	chr19:41381400-41382000	Enhancers	Lung	lung
40	chr19:41381600-41381800	Weak transcription	Primary monocytes fromperipheralblood	blood
41	chr19:41381600-41381800	Active TSS	Adipose Nuclei	Adipose
42	chr19:41381600-41381800	Active TSS	Fetal Intestine Large	intestine
43	chr19:41381600-41382000	Enhancers	Primary B cells from peripheral blood	blood
44	chr19:41381600-41382000	Active TSS	Primary T helper cells fromperipheralblood	blood
45	chr19:41381600-41382200	Active TSS	Primary B cells from cord blood	blood
46	chr19:41381600-41382200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
47	chr19:41381600-41382600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
48	chr19:41381600-41383200	Enhancers	Primary neutrophils fromperipheralblood	blood
49	chr19:41381800-41382000	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
50	chr19:41381800-41382200	Flanking Active TSS	K562	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links